Glycogen synthase kinase 3 beta regulates glial glutamate transporter protein expression in the spinal dorsal horn in rats with neuropathic pain

Experimental Neurology

Volumn 252, Issue , 2014, Pages 18-27

  Weng, Han Rong ^a   Gao, Mei ^a   Maixner, Dylan W ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Dorsal horn; Glutamate transporter; GSK3 ; GSK3beta; IL 1 ; Interleukin 1beta; Nociception; Pain

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 1BETA; VESICULAR GLUTAMATE TRANSPORTER 1;

ADULT; ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GLIA; HYPERALGESIA; MALE; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; YOUNG ADULT;

DORSAL HORN; GLUTAMATE TRANSPORTER; GSK3BETA; GSK3Β; IL-1Β; INTERLEUKIN-1BETA; NOCICEPTION; PAIN;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; ENZYME INHIBITORS; EXCITATORY AMINO ACID TRANSPORTER 2; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOGEN SYNTHASE KINASE 3; HYPERALGESIA; INTERLEUKIN-1BETA; MALE; NEURONS; ONCOGENE PROTEIN V-AKT; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SCIATICA; SERINE; SPINAL CORD; THIAZOLES; TIME FACTORS; UREA;

EID: 84890034960     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.11.018     Document Type: Article

References (67)

1. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
2. Beurel E., Michalek S.M., Jope R.S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 2010, 31:24-31.
3. Bhat R., Xue Y., Berg S., Hellberg S., Ormö M., Nilsson Y., Radesäter A.-C., Jerning E., Markgren P.-O., Borgegård T., Nylöf M., Giménez-Cassina A., Hernández F., Lucas J.J., Díaz-Nido J., Avila J. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J. Biol. Chem. 2003, 278:45937-45945.
4. Cata J.P., Weng H.R., Dougherty P.M. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res. 2008, 1229:100-110.
5. Cirillo G., Bianco M.R., Colangelo A.M., Cavaliere C., Daniele de L., Zaccaro L., Alberghina L., Papa M. Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor. Neurobiol. Dis. 2011, 41:630-639.
6. Clark A.K., D'Aquisto F., Gentry C., Marchand F., McMahon S.B., Malcangio M. Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation. J. Neurochem. 2006, 99:868-880.
7. Clark A.K., Yip P.K., Grist J., Gentry C., Staniland A.A., Marchand F., Dehvari M., Wotherspoon G., Winter J., Ullah J., Bevan S., Malcangio M. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10655-10660.
8. Clements J.D. Transmitter timecourse in the synaptic cleft: its role in central synaptic function. Trends Neurosci. 1996, 19:163-171.
9. Coghlan M.P., Culbert A.A., Cross D.A.E., Corcoran S.L., Yates J.W., Pearce N.J., Rausch O.L., Murphy G.J., Carter P.S., Roxbee Cox L., Mills D., Brown M.J., Haigh D., Ward R.W., Smith D.G., Murray K.J., Reith A.D., Holder J.C. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 2000, 7:793-803.
10. Colangelo A.M., Cirillo G., Lavitrano M.L., Alberghina L., Papa M. Targeting reactive astrogliosis by novel biotechnological strategies. Biotechnol. Adv. 2012, 30:261-271.
11. Cruz Duarte P., St-Jacques B., Ma W. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model. Exp. Neurol. 2012, 234:466-481.
12. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
13. De Sarno P., Axtell R.C., Raman C., Roth K.A., Alessi D.R., Jope R.S. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 2008, 181:338-345.
14. DeLeo J.A., Colburn R.W., Rickman A.J. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 1997, 759:50-57.
15. Dimitrov E.L., Kuo J., Kohno K., Usdin T.B. Neuropathic and inflammatory pain are modulated by tuberoinfundibular peptide of 39 residues. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:13156-13161.
16. Doyle T., Chen Z., Muscoli C., Bryant L., Esposito E., Cuzzocrea S., Dagostino C., Ryerse J., Rausaria S., Kamadulski A., Neumann W.L., Salvemini D. Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain. J. Neurosci. 2012, 32:6149-6160.
17. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 2001, 65:391-426.
18. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
19. Ji R.R., Suter M.R. p38 MAPK, microglial signaling, and neuropathic pain. Mol. Pain 2007, 3:33.
20. Jiang E., Yan X., Weng H.R. Glial glutamate transporter and glutamine synthetase regulate GABAergic synaptic strength in the spinal dorsal horn. J. Neurochem. 2012, 121:526-536.
21. Jin S.X., Zhuang Z.Y., Woolf C.J., Ji R.R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 2003, 23:4017-4022.
22. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 2007, 32:577-595.
23. Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., Gao Y.J., Roy K., Corfas G., Lo E.H., Ji R.R. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med. 2008, 14:331-336.
24. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 2008, 28:5189-5194.
25. Kim S.Y., Bae J.C., Kim J.Y., Lee H.L., Lee K.M., Kim D.S., Cho H.J. Activation of p38 MAP kinase in the rat dorsal root ganglia and spinal cord following peripheral inflammation and nerve injury. Neuroreport 2002, 13:2483-2486.
26. Kleibeuker W., Gabay E., Kavelaars A., Zijlstra J., Wolf G., Ziv N., Yirmiya R., Shavit Y., Tal M., Heijnen C.J. IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2. Brain Behav. Immun. 2008, 22:200-208.
27. Lee H.L., Lee K.M., Son S.J., Hwang S.H., Cho H.J. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 2004, 15:2807-2811.
28. Li L.B., Toan S.V., Zelenaia O., Watson D.J., Wolfe J.H., Rothstein J.D., Robinson M.B. Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J. Neurochem. 2006, 97:759-771.
29. Liaw W.J., Stephens R.L., Binns B.C., Chu Y., Sepkuty J.P., Johns R.A., Rothstein J.D., Tao Y.X. Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 2005, 115:60-70.
30. Liou J.T., Lee C.M., Lin Y.C., Chen C.Y., Liao C.C., Lee H.C., Day Y.J. P-selectin is required for neutrophils and macrophage infiltration into injured site and contributes to generation of behavioral hypersensitivity following peripheral nerve injury in mice. Pain 2013, 154:2150-2159.
31. Martins D.F., Rosa A.O., Gadotti V.M., Mazzardo-Martins L., Nascimento F.P., Egea J., Lopez M.G., Santos A.R. The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice. J. Pain 2011, 12:315-322.
32. Mazzardo-Martins L., Martins D.F., Stramosk J., Cidral-Filho F.J., Santos A.R. Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action. Neuroscience 2012, 226:411-420.
33. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 2009, 10:23-36.
34. Nie H., Weng H.R. Glutamate transporters prevent excessive activation of NMDA receptors and extrasynaptic glutamate spillover in the spinal dorsal horn. J. Neurophysiol. 2009, 101:2041-2051.
35. Nie H., Weng H.R. Impaired glial glutamate uptake induces extrasynaptic glutamate spillover in the spinal sensory synapses of neuropathic rats. J. Neurophysiol. 2010, 103:2570-2580.
36. Nie H., Zhang H., Weng H.R. Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic rats. Neuroscience 2010, 170:901-912.
37. Parkitna J.R., Obara I., Wawrzczak-Bargiela A., Makuch W., Przewlocka B., Przewlocki R. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats. J. Pharmacol. Exp. Ther. 2006, 319:832-839.
38. Raghavendra V., Tanga F., DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 2003, 306:624-630.
39. Raghavendra V., Tanga F.Y., DeLeo J.A. Complete Freund adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 2004, 20:467-473.
40. Ren K., Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr. Opin. Anaesthesiol. 2008, 21:570-579.
41. Ren K., Dubner R. Interactions between the immune and nervous systems in pain. Nat. Med. 2010, 16:1267-1276.
42. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J., Woolf C.J. Interleukin-1á-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-475.
43. Seltzer Z.e, Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990, 43:205-218.
44. Shamash S., Reichert F., Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 2002, 22:3052-3060.
45. Sommer C., Petrausch S., Lindenlaub T., Toyka K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. 1999, 270:25-28.
46. Sugden P.H., Fuller S.J., Weiss S.C., Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br. J. Pharmacol. 2008, 153(Suppl. 1):S137-S153.
47. Sun X., Sato S., Murayama O., Murayama M., Park J.M., Yamaguchi H., Takashima A. Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100. Neurosci. Lett. 2002, 321:61-64.
48. Sun L., Wu Z., Hayashi Y., Peters C., Tsuda M., Inoue K., Nakanishi H. Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain. J. Neurosci. 2012, 32:11330-11342.
49. Sung B., Lim G., Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J. Neurosci. 2003, 23:2899-2910.
50. Sung B., Wang S., Zhou B., Lim G., Yang L., Zeng Q., Lim J.A., Wang J.D., Kang J.X., Mao J. Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats. Pain 2007, 131:121-131.
51. Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 1993, 296(Pt 1):15-19.
52. Sweitzer S.M., Schubert P., DeLeo J.A. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J. Pharmacol. Exp. Ther. 2001, 297:1210-1217.
53. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
54. Tao F., Tao Y.X., Mao P., Johns R.A. Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in rats. Neuroscience 2003, 117:731-739.
55. Weng H.R., Aravindan N., Cata J.P., Chen J.H., Shaw A.D., Dougherty P.M. Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia. Neurosci. Lett. 2005, 386:18-22.
56. Weng H.R., Chen J.H., Cata J.P. Inhibition of glutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation. Neuroscience 2006, 138:1351-1360.
57. Weng H.R., Chen J.H., Pan Z.Z., Nie H. Glial glutamate transporter 1 regulates the spatial and temporal coding of glutamatergic synaptic transmission in spinal lamina II neurons. Neuroscience 2007, 149:898-907.
58. Wolf G., Gabay E., Tal M., Yirmiya R., Shavit Y. Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autonomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 2006, 120:315-324.
59. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 1990, 9:2431-2438.
60. Xu J.-T., Tu H.-Y., Xin W.-J., Liu X.-G., Zhang G.-H., Zhai C.-H. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats. Exp. Neurol. 2007, 206:269-279.
61. Xu Q., Fitzsimmons B., Steinauer J., O'Neill A., Newton A.C., Hua X.-Y., Yaksh T.L. Spinal phosphinositide 3-kinase-akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia. J. Neurosci. 2011, 31:2113-2124.
62. Yaksh T.L., Rudy T.A. Analgesia mediated by a direct spinal action of narcotics. Science 1976, 192:1357-1358.
63. Yan X., Weng H.R. Endogenous interleukin-1β in neuropathic rats enhances glutamate release from the primary afferents in the spinal dorsal horn through coupling with presynaptic N-methyl-D-aspartic acid receptors. J. Biol. Chem. 2013, 288:30544-30557.
64. Yuan Y., Wang J.Y., Yuan F., Xie K.L., Yu Y.H., Wang G.L. Glycogen synthase kinase-3beta contributes to remifentanil-induced postoperative hyperalgesia via regulating N-methyl-d-aspartate receptor trafficking. Anesth. Analg. 2013, 116:473-481.
65. Zhang R.X., Liu B., Wang L., Ren K., Qiao J.T., Berman B.M., Lao L. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 2005, 118:125-136.
66. Zhang R.X., Li A., Liu B., Wang L., Ren K., Zhang H., Berman B.M., Lao L. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008, 135:232-239.
67. Zhang X., Chen G., Xue Q., Yu B. Early changes of β-catenins and menins in spinal cord dorsal horn after peripheral nerve injury. Cell. Mol. Neurobiol. 2010, 30:885-890.